The first private incubator of microbiome biotech companies
At Nexbiome Therapeutics, we define the microbiome as an ecosystem of microorganisms, the composition of which predisposes to health or to illness. Consequently, we are convinced that the microbiome represents the reservoir of therapeutic solutions for the future of human health.
Our mission is to identify the best research projects and turn them into biotech companies that will bring innovative health solutions to the market. Our ambition is to contribute to the emergence of global champions in every therapeutic segment for which health through the microbiome makes sense.
Our missions
As a picture tells a thousand words
Our competences
Our platform of competences brings together three key areas:
Evaluation
Assessment of projects in relation to patient’s need and the scientific state-of-the-art
Development
Complete control over pharmaceutical development, from discovery to product registration
Financing
Finance engineering on equity and via financial partners
Our values and principles for action
Respect
Thirst for discovery
Mental and physical mobility
Value creation through collaborative work
Pipeline
| Project Code | Pathology | Techno | Discovery | Preclinical | Phase 1 | Phase 2 | Phase 3 | Regulatory Approval |
|---|---|---|---|---|---|---|---|---|
| BGA-1901 | H.Pylori infections | LBP |  |
|||||
| BGY-1601 | Acute vaginitis | LBP | |
|||||
| BGA-1601 | Ulcerative colitis | Recombinant LBP | |
|||||
| BRH-1101 | Osteoarthritis | Postbiotic | |
Team
Nos partenaires
Nos compétences internes s'enrichissent grâce à un réseau d'Universités spécialisées en immunologie, galénique, bio-informatiques, étude animales...
Dernières actualités
Let's keep in touch
Subscribe to our newsletter to keep up to date with Nexbiome news.